ESPR today

$3.18-$0.01 (-0.31%)close Jul 10, 2026

Trend

DailyDowntrend (confirmed)

4 hourStrong Bullish

1 hourBullish

15 minBullish

5 minNo data

Daily trend turns up above $2.89

Key levels

Resistance$3.27

Resistance$3.25

Support$3.16

Support$3.11

Esperion Therapeutics, Inc. (ESPR)

$3.18-0.01 (-0.31%)

HOLDGrade: C+Risk: MEDIUM

1D 5D1M1Y 5Y MaxSign up for all timeframes

High3.19

Low3.18

Open3.18

Volume56.48M

Avg Vol13.50M

VWAP3.18

30d High3.19

30d Low3.13

30d Chg+1.60%

See full chart with real-time data

What Is the Price Target for ESPR?

SEPT Low Target

$2.69

SEPT Mid Target

$3.16

SEPT High Target

$3.63

Analyst Consensus

$3.16

Current: $3.18Upside: -0.6%Confidence: 40%Method: Analyst Consensus

Is ESPR a Buy or Sell Right Now?

Investability Score

HOLD12-18 months

Thesis

•Revenue growing 21.3% YoY with STRONG trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ESPR.

Start Free Trial →

Is ESPR Overvalued or Undervalued?

Valuation Verdict

OVERVALUED

Methods Used

PEG, Analyst Consensus

Fair Value

$2.95

Moat Score

NONE

4/9

Piotroski Score

-2.6

Altman Z-Score

What Is Smart Money Doing with ESPR?

Insider Signal

SELLING

0 buys / 4 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

UNCHANGED

Short Squeeze Risk

LOW

Signal: NEUTRAL

Recent Insider Activity

Name	Title	Type	Shares	Value	Date
THOMPSON JOHN CRAIG	director	Buy	79,873	-	May 28, 2026
Shepard Jay	director	Buy	79,873	-	May 28, 2026
Hoffman Robert E.	director	Buy	79,873	-	May 28, 2026
Fischer Seth H. Z.	director	Buy	79,873	-	May 28, 2026
CARROLL J MARTIN	director	Buy	79,873	-	May 28, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

ESPR Growth Story

Revenue YoY

21.3%

3yr Revenue CAGR

N/A%

EPS Growth YoY

60.71%

FCF Growth YoY

45.4%

Revenue Trend

STRONG

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Esperion Therapeutics, Inc. (ESPR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (8 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

ESPR — frequently asked questions

What is ESPR stock price today?

Esperion Therapeutics, Inc. (ESPR) is at $3.18, down 0.31% (-$0.01) at the Jul 10, 2026 close.

What is the ESPR price target?

The average analyst price target for ESPR is $3.16, ranging from $3 to $3, based on 1 analysts. Latest: HC Wainwright & Co. downgrade on May 1, 2026.

What do analysts rate ESPR?

Analyst ratings for ESPR: 0 Buy, 0 Hold, 2 Sell — consensus Sell.

Does ESPR pay a dividend?

ESPR does not currently pay a dividend.

What are ESPR support and resistance levels?

Support: $3.16, $3.11, $2.89. Resistance: $3.25, $3.27, $3.38.

What are insiders doing with ESPR?

Insider activity: SELLING, 0 buys and 4 sells in the last 90 days.